Evidence map›Paper›PMID 31015378›Full record

ArticleBMJ quality & safety2019

What US hospitals are currently doing to prevent common device-associated infections: results from a national survey.

Sanjay Saint, Michael Todd Greene, Karen E Fowler, David Ratz, Payal K Patel, Jennifer Meddings, Sarah L Krein

Open access · hybridAbstract read
In one paragraph

Article in BMJ quality & safety, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Increased Involvement ofHealthcare (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sanjay SaintCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA saint@med.umich.edu.ORCID 0000-0002-9579-6990
Michael Todd GreeneCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Karen E FowlerCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.ORCID 0000-0001-8274-8407
David RatzCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Payal K PatelDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Jennifer MeddingsCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Sarah L KreinCenter for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.ORCID 0000-0003-2111-8131
University of Michigan · USVA Ann Arbor Healthcare System · US

Funding

HSRD VA IK6 HX003399HSRD VA RCS 11-222
6 · The paper itself

Abstract

backgroundDespite focused initiatives to reduce device-associated infection among hospitalised patients, the practices US hospitals are currently using are unknown. We thus used a national survey to ascertain the use of several established and novel practices to prevent device-associated infections.

methodsWe mailed surveys to infection preventionists in a random sample of nearly 900 US acute care hospitals in 2017. Our survey asked about the use of practices to prevent three common device-associated infections: catheter-associated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI) and ventilator-associated pneumonia (VAP). Using sample weights, we estimated the percentage of hospitals reporting regular use of each practice. We also conducted multivariable regression to determine associations between selected hospital characteristics (eg, perceived support from leadership) and use of CAUTI, CLABSI and VAP prevention practices.

resultsThe response rate was 59%. Several practices are reportedly used in over 90% of US hospitals: aseptic technique during indwelling urethral catheter insertion and maintenance (to prevent CAUTI); maximum sterile barrier precautions during central catheter insertion and alcohol-containing chlorhexidine gluconate for insertion site antisepsis (to prevent CLABSI); and semirecumbent positioning of the patient (to prevent VAP). Antimicrobial devices are used in the minority of hospitals for these three device-associated infections.

conclusionsWe provide an updated snapshot of the practices US hospitals are currently using to prevent device-associated infections. Compared with previous studies using a similar design and questions, we found that the use of recommended practices increased in US hospitals, especially for CAUTI prevention.

Indexed as

HospitalsCatheter-Related InfectionsClinical ProtocolsHealth Care SurveysHumansInfection ControlPneumonia, Ventilator-AssociatedRegression AnalysisUnited Stateshospitalinfection controlnosocomial infectionpatient safety

Identifiers

PMID31015378
PMCPMC6820292
OpenAlexW2940860322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.